Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome (RADAR)
This study has been completed.
Study NCT00932100 Information provided by Regado Biosciences, Inc.
First Received on July 1, 2009. Last Updated on March 1, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Acute Coronary Syndrome (ACS)
Additional conditions recognized in this trial
Acute Coronary Syndrome
More general conditions related to this trial
Signs and Symptoms
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Sponsors listed in this trial
Regado Biosciences, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers